← Back to contracts

Novel Markers for Disease Outcome in Breast Cancer

US · IL NIH grant open #nih-1ZIABC010887-18

Summary

Research investigating the biological mechanisms through which chronic stressors and genetic ancestry influence breast cancer outcomes, particularly focusing on health disparities in African American women.

What they want

Project 1 investigated proteomic, transcriptomic, and genomic effects of multilevel chronic stressors (perceived stress, social support, discrimination, neighborhood deprivation) in 121 African American and European American women with breast cancer. It involved patient surveys, collection of tumor and blood samples, and analysis of stress-related factors on immune-inflammation markers and tumor characteristics. Findings indicated chronic stressor-induced inflammation and immune dysfunction are associated with increased breast cancer aggressiveness and disparities, especially in African American women. Project 2 employed single-nucleus ATAC- and RNA-sequencing of 82 frozen breast tumors from African American, Kenyan, and European American women to characterize chromatin accessibility and gene expression patterns at single-cell resolution in relation to genetic ancestry, risk factors, and survival. A new protocol for isolating single nuclei from archival tissue was established, and a new analytic pipeline for Multiome sequencing data was developed. The project identified distinct pro-tumorigenic and immune-suppressive microenvironment characteristics in women of African descent predictive of survival.
Deliverables
  • Manuscript drafted and to be submitted for publication in 2025
Technical requirements
  • Proteomic analysis
  • Transcriptomic analysis
  • Genomic analysis
  • Single-nucleus ATAC-sequencing
  • Single-nucleus RNA-sequencing
  • Optimized combination of enzymatic digestion and automated tissue homogenization for single nuclei isolation
  • Analytic pipeline for Multiome sequencing data
  • DNA copy number analysis (CopyKat)

Risks & flags

  • This document describes completed and ongoing research projects, not a procurement opportunity. There are no indications of a buyer seeking bids, no response due date, no submission format, and no evaluation criteria.
Novel Markers for Disease Outcome in Breas…
Onboard